Epia Neuro’s brain-computer interface will include a motorized glove to help stroke patients recover movement in their hand. Stroke is one of the leading causes of long-term disability, with roughly ...

Cass McCombs recently kicked off his tour to bring last year's Interior Live Oak to the stage. In New York, he was introduced by comedian Adam Friedland, who called him "the greatest singer-songwriter ...

Denali Therapeutics’ tividenofusp alfa (Avlayah) has secured accelerated approval for Hunter syndrome, a rare metabolic disease. The first-in-modality biologic — an enzyme fused to a blood–brain ...

Hunter syndrome patients can manage the disorder with a drug that addresses disease symptoms throughout the body except the brain — a key limitation for treating this rare neurological disorder. The ...

Please provide your email address to receive an email when new articles are posted on . Hand-foot syndrome is a painful adverse event from chemotherapy, particularly capecitabine. Data show an ...

For individuals living with fragile X syndrome — a common genetic disorder that is correlated with autism, causes intellectual disability and more frequently affects male individuals — anxiety, ...

AHS is often caused by brain injury or neurodegenerative illnesses, but there is not enough research to determine any consistent cause or why it occurs. “Alien hand is little investigated because it ...

China has approved its first-ever invasive brain-computer interface product, marking a key regulatory milestone in Chinese startups’ quest to challenge US rivals such as Elon Musk-backed Neuralink ...

Researchers have discovered a new way to increase a key brain protein damaged in Rett syndrome, a rare genetic disorder that affects thousands of children worldwide. Early studies in mice and ...

In this detail of a figure from the paper, Rett syndrome endothelial cells (right) show less expression of ZO-1 (green), a key protein for forming a tight seal in blood vessels. Control cells (left) ...

After facing a delayed decision deadline and a clinical hold, Regenxbio’s Hunter syndrome gene therapy has been rejected by the FDA. In rejecting RGX-121, the FDA raised concerns about its clinical ...